Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01379599 · ClinicalTrials.gov registry record · Phase 3

Brief Intervention to Reduce STDs in ER Drug Users

A Phase 3 study, sponsored by Boston Medical Center.

Completed
Registry status
Phase 3
Development phase
1,030
Enrollment target

NCT01379599 is a Phase 3 study that has completed, run by Boston Medical Center. The registered enrollment target is 1,030 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01379599, a Phase 3 study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
Phase 3
Development phase
1,030 participants
Enrollment target

Study Summary

The goal of the proposed project is to determine the effectiveness of a brief motivational intervention among Emergency Department (ED) patients who use cocaine and/or heroin to prevent Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) by comparing cumulative incidence and frequency of safe sex behavior between intervention and standard voluntary counseling, testing and referral to substance abuse treatment (control) groups over a one year follow-up period.

Interventions

  • BEHAVIORAL brief motivation intervention

Trial Details

FieldValue
Enrollment Target 1,030 participants
Start Date 2004-11
Est. Completion 2009-05
Phase Phase 3

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT01379599

The ClinicalTrials.gov registry entry for NCT01379599 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which brief motivation intervention is the first listed.

NCT01379599 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01379599 about?

NCT01379599 is a clinical study titled "Brief Intervention to Reduce STDs in ER Drug Users". The goal of the proposed project is to determine the effectiveness of a brief motivational intervention among Emergency Department (ED) patients who use cocaine and/or heroin to prevent Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) by comparing cumulative incidence an...

What is the current status of trial NCT01379599?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,030 participants. The study started on 2004-11. Estimated completion is 2009-05.

What interventions are being tested in trial NCT01379599?

The interventions under investigation include: brief motivation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01379599?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.